Citation only
via Europe PMC
Predictors of loss to follow-up in neovascular age-related macular degeneration.
Huang RS, Naidu SC, Mihalache A, Xie JS, Popovic MM, Kertes PJ, Sarraf D, Sadda SR, Muni RH, Kohly RP.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie · 2026
Abstract
<h4>Objective</h4>To investigate the demographic, clinical, and treatment-related risk factors associated with being lost to follow-up (LTFU) among patients with neovascular age-related macular degeneration (nAMD) receiving antivascular endothelial growth factor (anti-VEGF) intravitreal injections (IVIs).<h4>Methods</h4>We conducted a multicentre retrospective cohort study of patients with nAMD treated with anti-VEGF IVIs in Toronto, Ontario, from January 2012 to December 2021. LTFU was defined as the absence of an ophthalmic visit within 1 year of the last retinal specialist appointment. Univariable and multivariable logistic regression analyses were conducted to examine associations between demographic, clinical, and treatment-related factors and becoming LTFU.<h4>Results</h4>Among 2556 patients with nAMD, 527 (21%) were LTFU over a mean follow-up of 65.5 ± 15.2 months. In multivariable analysis, male sex (OR = 1.40; p < .001), greater travel distance (>200 km; OR = 2.51; p < .001), and multiple systemic comorbidities (≥3; OR = 1.39; p = .01) were associated with higher odds of LTFU. Compared with White patients, Black (OR = 2.07; p < .001) and Hispanic patients (OR = 1.70; p < .001) had increased odds of LTFU. In contrast, age ≥90 years (OR = 0.53; p < .001), worse baseline visual acuity (>20/200; OR = 0.72; p = .03), pseudophakia (OR = 0.80; p = .04), bilateral disease (OR = 0.72; p = .01), and higher first-year anti-VEGF injection burden (OR = 0.55; p < .001) were associated with lower odds of LTFU.<h4>Conclusions</h4>Male sex, Black or Hispanic race/ethnicity, multiple systemic comorbidities, and greater travel distance were associated with increased odds of becoming LTFU, while older age, worse baseline visual acuity, pseudophakia, bilateral disease, and higher IVI burden were protective factors. These findings can inform the development of targeted retention strategies for high-risk patients.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- DOI
- 10.1016/j.jcjo.2026.08.006
- Canonical
- link ↗
- Fetched
- 2026-10-10 MST
Cite this
APA
RS, H., SC, N., A, M., JS, X., MM, P., PJ, K., D, S., SR, S., RH, M., & RP., K. (2026). Predictors of loss to follow-up in neovascular age-related macular degeneration. <em>Canadian journal of ophthalmology. Journal canadien d'ophtalmologie</em>. https://doi.org/10.1016/j.jcjo.2026.08.006
Vancouver
RS H, SC N, A M, JS X, MM P, PJ K, et al. Predictors of loss to follow-up in neovascular age-related macular degeneration. Canadian journal of ophthalmology. Journal canadien d'ophtalmologie. 2026. doi:10.1016/j.jcjo.2026.08.006.
BibTeX
@article{huang2026Predic,
title = {Predictors of loss to follow-up in neovascular age-related macular degeneration.},
author = {Huang RS and Naidu SC and Mihalache A and Xie JS and Popovic MM and Kertes PJ and Sarraf D and Sadda SR and Muni RH and Kohly RP.},
journal = {Canadian journal of ophthalmology. Journal canadien d'ophtalmologie},
year = {2026},
doi = {10.1016/j.jcjo.2026.08.006},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Science 1997
Citation only
Mutation of the Stargardt Disease Gene ( ABCR ) in Age-Related Macular Degeneration
Neurology 2008
Open access · OA
Physical frailty in older persons is associated with Alzheimer disease pathology
American Journal of Epidemiology 1995
Citation only
Age-related Macular Degeneration Is Associated with Atherosclerosis
Alzheimer s & Dementia 2023
Open access · OA
Proteomic‐based Biological Aging Clock and MRI Markers of Cerebrovascular Disease: Atherosclerosis Risk in Community Study
The Journals of Gerontology Series A 2023
Open access · CC-BY
Epigenetic Age Acceleration and Chronological Age: Associations With Cognitive Performance in Daily Life
Frontiers in Public Health 2025
Open access · CC-BY